FDCDDQ
CTXR icon

Federation des caisses Desjardins du Quebec’s Citius Pharmaceuticals CTXR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72 Hold
80
– – ﹤0.01% 2910
2025
Q4 		$61 Hold
80
– – ﹤0.01% 2829
2025
Q3 		$99 Hold
80
– – ﹤0.01% 2808
2025
Q2 		$127 Hold
80
– – ﹤0.01% 2650
2025
Q1 		$119 Buy
+80
New +$191 ﹤0.01% 2585

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CTXR Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Citius Pharmaceuticals (CTXR) position steady in Q1 2026 at 80 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

Federation des caisses Desjardins du Quebec first reported a position in CTXR in Q1 2025 and has held it in 5 quarters since. The position peaked at $127 in Q2 2025. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 80 shares of Citius Pharmaceuticals worth $72 as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Citius Pharmaceuticals share count unchanged in Q1 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2910 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Citius Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Federation des caisses Desjardins du Quebec's Citius Pharmaceuticals position peaked at $127 in Q2 2025.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.